Sign in

CIK 0001677077

  • Emerging growth company

Alzamend Neuro, Inc.

Sign in to watch
Ticker
ALZN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Apr 30
Incorporated
DE
Entity type
Operating
EIN
811822909
Phone
+1 844-722-6333
Business address
480 PEACHTREE ROAD NE, SECOND FLOOR, SUITE 103, ATLANTA, GA, 30326
  1. 4 Insider Changes in Ownership
  2. 4 Derivatives Options or other derivatives
  3. 4 Open-market buy 10% owner bought 1,000 shares at $1.29 ($1,289)
  4. 4 Other acquisition 10% owner acquired 933,334 shares (other)
  5. 4 Open-market buy 10% owner bought 1,000 shares at $1.13 ($1,130)
  6. 4 Open-market buy 10% owner bought 6,000 shares at $1.19 ($7,136)
  7. 4 Open-market buy 10% owner bought 2,000 shares at $1.23 ($2,467)
  8. 4 Open-market buy 10% owner bought 1,000 shares at $1.43 ($1,429)
  9. 4 Open-market buy 10% owner bought 3,500 shares at $1.19 ($4,153)
  10. 4 Other acquisition 10% owner acquired 73,500 shares (other)
  11. 4 Open-market buy Chief Executive Officer bought 8,500 shares at $1.23 ($10,414)
  12. 4 Open-market buy Chief Financial Officer bought 10,000 shares at $1.11 ($11,092)
  13. 4 Open-market buy 10% owner bought 9,100 shares at $0.94 ($8,561)
  14. 4 Open-market buy 10% owner bought 4,900 shares at $0.96 ($4,704)
  15. 4 Open-market buy 10% owner bought 36,000 shares at $0.97 ($34,895)
  16. 4 Open-market buy 10% owner bought 15,000 shares at $1.08 ($16,214)
  17. 4 Open-market buy 10% owner bought 14,000 shares at $1.06 ($14,833)
  18. 4 Open-market buy 10% owner bought 1,000 shares at $1.04 ($1,040)
  19. 4 Open-market buy 10% owner bought 2,000 shares at $0.95 ($1,896)
  20. 4 Open-market buy 10% owner bought 5,700 shares at $0.87 ($4,959)

Page 4 of 9 · 170 filings